Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.15)
# 2,735
Out of 4,732 analysts
283
Total ratings
58.02%
Success rate
-1.45%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Underweight | $183 → $195 | $216.59 | -9.97% | 6 | Dec 17, 2024 | |
| AMWL American Well | Maintains: Equal-Weight | $20 → $11 | $9.55 | +9.95% | 5 | Dec 17, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $7 → $6 | $4.57 | +31.29% | 2 | Dec 17, 2024 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $406 → $355 | $310.45 | +14.35% | 2 | Dec 17, 2024 | |
| HIMS Hims & Hers Health | Initiates: Overweight | $42 | $27.85 | +50.81% | 1 | Dec 17, 2024 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $123 → $97 | $134.75 | -28.01% | 14 | Nov 5, 2024 | |
| ARDT Ardent Health Partners | Initiates: Overweight | $27 | $14.10 | +91.49% | 1 | Aug 12, 2024 | |
| DH Definitive Healthcare | Maintains: Equal-Weight | $9 → $5 | $3.94 | +26.90% | 12 | Aug 6, 2024 | |
| SWKS Skyworks Solutions | Maintains: Equal-Weight | $96 → $114 | $93.64 | +21.74% | 24 | Feb 7, 2023 | |
| ST Sensata Technologies Holding | Maintains: Overweight | $62 → $57 | $28.42 | +100.56% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $57.97 | +39.73% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $53.72 | -34.85% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $15.90 | +13.21% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $84.21 | +119.69% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $145.72 | +14.60% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $69.42 | -39.50% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $151.20 | +5.16% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $52.62 | +137.55% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $237.44 | -69.55% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $192.42 | +1.34% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $509.76 | -4.27% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $286.21 | +3.42% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $238.56 | +54.26% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $282.63 | +81.51% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $283.99 | -3.17% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $62.25 | +41.37% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $54.63 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $83.14 | +122.52% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $215.36 | -1.10% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $131.94 | -56.04% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $219.16 | -46.61% | 15 | Jun 16, 2020 |
Veeva Systems
Dec 17, 2024
Maintains: Underweight
Price Target: $183 → $195
Current: $216.59
Upside: -9.97%
American Well
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20 → $11
Current: $9.55
Upside: +9.95%
GoodRx Holdings
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $4.57
Upside: +31.29%
HCA Healthcare
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $406 → $355
Current: $310.45
Upside: +14.35%
Hims & Hers Health
Dec 17, 2024
Initiates: Overweight
Price Target: $42
Current: $27.85
Upside: +50.81%
Silicon Laboratories
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $123 → $97
Current: $134.75
Upside: -28.01%
Ardent Health Partners
Aug 12, 2024
Initiates: Overweight
Price Target: $27
Current: $14.10
Upside: +91.49%
Definitive Healthcare
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $3.94
Upside: +26.90%
Skyworks Solutions
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $93.64
Upside: +21.74%
Sensata Technologies Holding
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $28.42
Upside: +100.56%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $57.97
Upside: +39.73%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $53.72
Upside: -34.85%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $15.90
Upside: +13.21%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $84.21
Upside: +119.69%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $145.72
Upside: +14.60%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $69.42
Upside: -39.50%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $151.20
Upside: +5.16%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $52.62
Upside: +137.55%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $237.44
Upside: -69.55%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $192.42
Upside: +1.34%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $509.76
Upside: -4.27%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $286.21
Upside: +3.42%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $238.56
Upside: +54.26%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $282.63
Upside: +81.51%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $283.99
Upside: -3.17%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $62.25
Upside: +41.37%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $54.63
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $83.14
Upside: +122.52%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $215.36
Upside: -1.10%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $131.94
Upside: -56.04%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $219.16
Upside: -46.61%